Generally speaking, we go to great lengths to rid our bodies of foreign bacteria, whether it’s by brushing our teeth, washing our hands or taking antibiotics. But new research suggests that when it comes to treating tumors, we may one day invite the bugs in. According to a study published yesterday in the early online edition of the Proceedings of the National Academy of Sciences, a bacterium that normally resides in soil, dust and dead flesh quickly destroys large tumors in mice when injected along with chemotherapy drugs.
Current cancer treatments are limited in part by their inability to destroy poorly vascularized areas of tumors: radiation requires oxygen to kill cells and chemotherapy drugs demand a blood system to reach their target. Anaerobic bacteria, on the other hand, actually prefer oxygen-free, or hypoxic, environments. Researchers have thus wondered for some time whether such bacteria might prove useful in combating tumors. Now Bert Vogelstein of Johns Hopkins University and his colleagues have shown that they can be. "The idea is to selectively attack these tumors from inside with the bacteria and from the outside with chemotherapy," Vogelstein explains. The team genetically engineered the bacterium Clostridium novyi, producing a toxin-free strain that, when administered with conventional drugs, eliminated nearly half of the advanced tumors in their lab mice within 24 hours. The healthy tissues surrounding the tumors, in contrast, remained intact.
The team’s so-called combination bacteriolytic therapy (COBALT) did have some negative outcomes, however. As many as 45 percent of the mice with the largest tumors died after treatment, presumably because of toxins released by the deteriorating tumor cells. "Any therapy which dramatically shrinks tumors may be subject to this side effect," the authors note. Yet although such tumor lysis is difficult to control in mice, it may be more easily controlled in humans. Still, whether or not COBALT will even work against human tumors at all remains to be seen. Says team member Kenneth Kinzler: "We hope that this research will add a new dimension to cancer treatment but realize that the way tumors respond to treatment in mice can be different than in humans."
Kate Wong | Scientific American
UC San Diego cancer scientists identify new drug target for multiple tumor types
12.07.2019 | University of California - San Diego
Bacteria engineered as Trojan horse for cancer immunotherapy
04.07.2019 | Columbia University School of Engineering and Applied Science
Scientists at the University Würzburg and University Hospital of Würzburg found that megakaryocytes act as “bouncers” and thus modulate bone marrow niche properties and cell migration dynamics. The study was published in July in the Journal “Haematologica”.
Hematopoiesis is the process of forming blood cells, which occurs predominantly in the bone marrow. The bone marrow produces all types of blood cells: red...
For some phenomena in quantum many-body physics several competing theories exist. But which of them describes a quantum phenomenon best? A team of researchers from the Technical University of Munich (TUM) and Harvard University in the United States has now successfully deployed artificial neural networks for image analysis of quantum systems.
Is that a dog or a cat? Such a classification is a prime example of machine learning: artificial neural networks can be trained to analyze images by looking...
An international research group led by scientists from the University of Bayreuth has produced a previously unknown material: Rhenium nitride pernitride. Thanks to combining properties that were previously considered incompatible, it looks set to become highly attractive for technological applications. Indeed, it is a super-hard metallic conductor that can withstand extremely high pressures like a diamond. A process now developed in Bayreuth opens up the possibility of producing rhenium nitride pernitride and other technologically interesting materials in sufficiently large quantity for their properties characterisation. The new findings are presented in "Nature Communications".
The possibility of finding a compound that was metallically conductive, super-hard, and ultra-incompressible was long considered unlikely in science. It was...
An interdisciplinary research team at the Technical University of Munich (TUM) has built platinum nanoparticles for catalysis in fuel cells: The new size-optimized catalysts are twice as good as the best process commercially available today.
Fuel cells may well replace batteries as the power source for electric cars. They consume hydrogen, a gas which could be produced for example using surplus...
The fly agaric with its red hat is perhaps the most evocative of the diverse and variously colored mushroom species. Hitherto, the purpose of these colors was...
24.06.2019 | Event News
29.04.2019 | Event News
17.04.2019 | Event News
16.07.2019 | Physics and Astronomy
16.07.2019 | Power and Electrical Engineering
16.07.2019 | Information Technology